Aug 22, 20192:00 PM - 3:00 PM

The Evolving Outsourcing Landscape in Pharma R&D: Pros and Cons of Different Models

The execution of drug discovery and development in pharma has changed dramatically in the last 20 years. Pharmaceutical companies no longer rely solely on large groups of internal scientists to generate ideas and execute the science, but have turned to contract research organizations (CROs) for their research and development needs. Join Bart DeCorte of MercachemSyncom for an overview of the drivers behind this radical transformation.